BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mitsumoto-Kaseida F, Murata M, Takayama K, Toyoda K, Ogawa E, Furusyo N, Hayashi J. Prevalence and characteristics of occult hepatitis B virus infection in Japanese human immunodeficiency virus-infected patients. J Infect Chemother 2020;26:28-32. [PMID: 31279522 DOI: 10.1016/j.jiac.2019.06.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 de Almeida NAA, de Paula VS. Occult Hepatitis B virus (HBV) infection and challenges for hepatitis elimination: A literature review. J Appl Microbiol 2021. [PMID: 34724308 DOI: 10.1111/jam.15351] [Reference Citation Analysis]
2 Sarmati L, Malagnino V. HBV Infection in HIV-Driven Immune Suppression. Viruses 2019;11:E1077. [PMID: 31752284 DOI: 10.3390/v11111077] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
3 Salpini R, Malagnino V, Piermatteo L, Mulas T, Alkhatib M, Scutari R, Teti E, Cerva C, Yu La Rosa K, Brugneti M, Bertoli A, Rossi B, Holzmayer V, Gersch J, Kuhns M, Cloherty G, Ceccherini-Silberstein F, Perno CF, Iannetta M, Andreoni M, Sarmati L, Svicher V. Cryptic HBV Replicative Activity Is Frequently Revealed in Anti-HBc-Positive/HBsAg-Negative Patients with HIV Infection by Highly Sensitive Molecular Assays, and Can Be Predicted by Integrating Classical and Novel Serological HBV Markers. Microorganisms 2020;8:E1819. [PMID: 33218205 DOI: 10.3390/microorganisms8111819] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Eltom K, Albeely A, El Hussein ARM, Elkhidir IM, Enan K. Occult hepatitis B virus infection in Sudan: A systematic review and meta-analysis. JGH Open 2020;4:800-7. [PMID: 33102748 DOI: 10.1002/jgh3.12411] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]